CSP 201310110029A
Declaration Data Announcement regarding the Proposed Rights Offer

Chemical Specialities Limited
Incorporated in the Republic of South Africa
Registration number: (2005/039947/06)
Share code: CSP
ISIN: ZAE000109427
("Chemspec" or "the Company")

DECLARATION DATA ANNOUNCEMENT REGARDING THE PROPOSED RIGHTS OFFER

1.    Introduction and amended terms of the rights offer

Shareholders are referred to the proposed rights offer announcement released
on the Stock Exchange News Service ("SENS") of the JSE Limited ("JSE") on 27
June 2013 and the revised terms announced on 2 August 2013, advising
shareholders that ChemSpec would be undertaking a capital raising of
R214,772,330 (before expenses) by way of a renounceable rights offer ("the
rights offer")

In terms of the rights offer, 536,930,824 new Chemspec compulsory
convertible preference shares ("rights offer CCPs") in the authorised but
unissued share capital of the Company, will be offered to Chemspec
shareholders recorded in the register at the close of trade on Friday, 1
November 2013 on the basis of 50 rights offer CCPs for every 100 Chemspec
shares held, at 40 cents per rights offer CCP. The rights offer is not being
underwritten.

2.    Conditions precedent

The rights offer is subject to the JSE Limited:
- granting a listing for the Letters of Allocation and the CCPs; and
- approving the rights offer circular and supporting documents.

3.    Purpose of the rights offer

The purpose of the rights offer is to raise capital to:
- fund organic growth initiatives;
- increase the balance sheet flexibility and proactively manage the
capital structure, better aligning the funding of the Group's long term
investments with long term capital and diversifying and improving
funding sources and additional borrowing capacity; and
- further improving working capital management, leveraging increased
liquidity to obtain better terms from suppliers and strategically
building inventory in an inflationary environment.


4.    Letters of Allocation
The rights to rights offer CCPs will be issued in dematerialised form and
are negotiable and can be sold on the JSE. The electronic record for
certificated shareholders will be maintained by Computershare Investor
Services (Proprietary) Limited. This will make it possible for certificated
shareholders, who are eligible to participate in the rights offer, to enjoy
the same rights and opportunities as those shareholders who have already
dematerialised their rights offer CCPs.


5.    Rights offer CCPs

The CCPs will be listed on the JSE under the following:
ISIN                                    ZAE000184305
Share Code                              CSPP
Short name                              Chemspecpref
Sector                                  Preference shares

6.     Irrevocable letters of undertaking

Chemspec has received irrevocable undertakings from shareholders holding in
the aggregate 688,880,723 Chemspec shares to follow their rights,
representing in aggregate 64.17% of the existing issued share capital of
Chemspec.

7.     Excess applications
Shareholders will be permitted to apply for rights offer shares in excess of
their entitlement. Any excess applications will be allocated to applicants
in an equitable manner by the company's directors.

8.     Foreign Jurisdictions

Non-resident shareholders may be affected by the rights offer, having regard
to prevailing laws in their respective jurisdictions. It is the
responsibility of all such persons (including without limitation, nominees
and trustees) wishing to accept the rights offer, to satisfy themselves of
the full observance of the laws of any relevant territory in connection
therewith, including obtaining any requisite governmental or other consents,
observing any other requisite formalities and paying any issue, transfer or
other taxes in connection therewith due in such territory. Non-resident
shareholders that are restricted in their respective jurisdiction cannot
participate in the rights offer and consequently their letters of
allocations will lapse.

9.     Financial effects of the rights offer

The financial effects of the rights offer are being finalised and will be
distributed by